That's the problem with a big P/E ratio. When the E stagnates and the earnings growth forecast crashes, the price goes through the floor pronto.Had been thinking of buying WTF but too expensive. Will have to have another look now.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025